Marı́a-José Camarasa

1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity

Rosa Álvarez, Sonsoles Velázquez, Ana San‐Félix et al. · Journal of Medicinal Chemistry · 1994 · 746 citations

Regiospecific Synthesis and Anti-Human Immunodeficiency Virus Activity of Novel 5-Substituted <i>N</i>-Alkylcarbamoyl and <i>N,N</i>-Dialkyl Carbamoyl 1,2,3-Triazole-TSAO Analogues

Sonsoles Velázquez, Rosa Álvarez, Carlos A. Perez et al. · Antiviral chemistry & chemotherapy · 1998 · 223 citations

Bioorganic Chemistry, Organic Chemistry, Antiviral Drug +16

2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.

Jan Balzarini, María‐Jesús Pérez‐Pérez, Ana San‐Félix et al. · Proceedings of the National Academy of Sciences · 1992 · 162 citations · Full text

Molecular Biology, Pharmacotherapy, Antiviral Drug +18

HIV-1-Specific Reverse Transcriptase Inhibitors Show Differential Activity against HIV-1 Mutant Strains Containing Different Amino Acid Substitutions in the Reverse Transcriptase

Jan Balzarini, Anna Karlsson, María‐Jesús Pérez‐Pérez et al. · Virology · 1993 · 153 citations

Human Retrovirus, Antiviral Drug Development, Reverse Transcriptase +9

3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2', 5'-bis-O-(tert-butyldimethylsilyl)-.beta.-D-xylo- and -ribofuranose]-3'-spiro-5''-[4''-amino-1'', 2''-oxathiole 2'', 2''-dioxide] (TSAO) pyrimidine nucleosides

Marı́a-José Camarasa, María‐Jesús Pérez‐Pérez, Ana San‐Félix et al. · Journal of Medicinal Chemistry · 1992 · 127 citations